Stockwatch: Fanfare For A Biotech Bottom
This article was originally published in Scrip
One of the most difficult parts of the jobs of investors and analysts is to predict the future. This can prove tricky so we fall back on our experience by associating what has happened in the past with what is likely to occur in the future. In taking the temperature prior to the start of this year's JP Morgan Healthcare conference I did not expect that almost every bearish prediction would come true and the stock price plummets that commenced that week would mark the start of one of the worst first-quarters for life science companies for many years.
Register for our free email digests: